This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
mtaschetta-millane Wed, 03/27/2024 - 08:08 March 27 2024 — HeartFlow, Inc. , HeartFlow Plaque Analysis is the only FDA cleared AI-enabled plaque quantification tool validated in a prospective international trial against the gold standard of invasive imaging (IVUS), with a reported 95% agreement.
The CaRi-Plaque technology supports non-invasive analysis of coronary anatomy and pathology from routine coronary computed tomography angiography (CCTA) scans to determine the presence, extent and severity of coronary plaques and luminal stenosis (narrowing of arteries). But with AI, we can change that.
milla1cf Tue, 01/16/2024 - 13:57 January 16, 2024 — Penumbra, Inc. , Now commercially available in Europe, CAT RX is designed to navigate tortuous coronary anatomy while maintaining sustained mechanical aspiration with the Penumbra ENGINE. We believe this can lead to better outcomes for the patient,” said James F.
milla1cf Thu, 05/23/2024 - 08:00 May 23, 2024 — HeartFlow, Inc. , a leader in non-invasive artificial intelligence (AI) heart care solutions, announced that the data from its REVEALPLAQUE study , highlighting the accuracy of its Plaque Analysis, was published in the European Heart Journal Cardiovascular Imaging.
tim.hodson Tue, 10/01/2024 - 10:50 PHOTO CAPTION: The Elucid PlaqueIQ user interface is a fully interactive visualization of the patient’s coronary anatomy, showing specific plaque type and amount across various views to inform physician assessment of risk and patient-specific treatment pathway.
First hs troponin I returned 108 minutes after ED arrival and was normal : (12 ng/L) _ No "upstream" P2Y12 were given in the ED ("upstream" means "before the angiogram "defines" the coronary anatomy). Angiography : --Culprit for the patient's unstable angina/Wellen syndrome is a ruptured plaque in the mid LAD. --As
And finally, after placement of a stent in the LAD: Before and after: (Unfortunately, this resulted in the "jailing" of the septal branches behind the stent and probably some degree of plaque shift which is why they do not opacify well in the "after" shot. This was the cost of preventing infarction of the anterior wall.)
24, which will be held April 6-8, 2024, at Atlanta at the Georgia World Congress Center. Bishop Keynote by Gerald Blackwell, MD, MBA, FAAC 2024 Keynote Presentations “We know what the growing complexity of coordinating care, multifaceted care and the need to really get the science up to the forefront.
The report describes heavy plaque in the proximal RCA by IVUS, but no lesions in the previously occluded RPL branch and no stent was deployed. Five days prior, she had a similar presentation to a different hospital. She underwent coronary angiography which showed thrombotic occlusion of an RPL branch s/p aspiration thrombectomy.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content